Literature DB >> 9378176

[The emigration of Italian patients to countries of the European Economic Community. Review of data published by the Ministry of Health].

E Crocetti1, M Geddes da Filicaia, N Crotti, E Dell'Olio, R Spigai.   

Abstract

In the present issue, the report "L'assistenza sanitaria all'estero-rapporti economici nei confronti dei Paesi CEE" by the Italian Health Ministry has been examined. The frequency and the cost of the health migration among Italy and other countries of the European Community during 1990-1993 has been presented. The migration of foreign patients to Italy was in agreement with tourism. About 35-40% of the Italian patients cured in the European Community were tourists. The others were patients migrated to obtain specialised treatments not available in Italy. The most frequent causes of migration were cancer, emathological diseases and radiotherapy, followed by transplants, neurological, cardiovascular and orthopaedic diseases. France was the most frequent destination. The overall cost of Italian health migration was 229 Pounds miliard in 1990, 300 Pounds miliard in 1991, and 264 and 216 Pounds miliard in 1992-1993. In the period analysed in the ministerial report, migration seemed to reduce. Migration however was still important especially from the South of Italy. The effect of the new regulations on the decreasing trend in migration was analysed.

Entities:  

Mesh:

Year:  1997        PMID: 9378176

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  1 in total

1.  Estimation of the real population and its impact on the utilisation of healthcare services in Mediterranean resort regions: an ecological study.

Authors:  Emilio Perea-Milla; Sergi Mari Pons; Francisco Rivas-Ruiz; Anna Gallofre; Enrique Navarro Jurado; Marco A Navarro Ales; Alberto Jimenez-Puente; Fidel Fernandez-Nieto; Joan C March Cerda; Manuel Carrasco; Lydia Martin; Damian Lopez Cano; Gonzalo E Gutierrez; Rafael Cortes Macías; Jose A Garcia-Ruiz
Journal:  BMC Health Serv Res       Date:  2007-01-31       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.